Coptisine inhibits RANKL-induced NF-κB phosphorylation in osteoclast precursors and suppresses function through the regulation of RANKL and OPG gene expression in osteoblastic cells

[1]  Ting Han,et al.  Antiosteoporotic chemical constituents from Er-Xian Decoction, a traditional Chinese herbal formula. , 2008, Journal of ethnopharmacology.

[2]  E. Sakai,et al.  Berberine inhibits RANKL-induced osteoclast formation and survival through suppressing the NF-kappaB and Akt pathways. , 2008, European journal of pharmacology.

[3]  Bo Tan,et al.  Simultaneous quantification of three alkaloids of Coptidis Rhizoma in rat urine by high‐performance liquid chromatography: application to pharmacokinetic study , 2007, Biopharmaceutics & drug disposition.

[4]  H. Takayanagi.  Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems , 2007, Nature Reviews Immunology.

[5]  Hiroshi Takayanagi,et al.  The molecular understanding of osteoclast differentiation. , 2007, Bone.

[6]  D. Fisher,et al.  Hyaluronan inhibits osteoclast differentiation via Toll-like receptor 4 , 2006, Journal of Cell Science.

[7]  Wei Wei,et al.  Effects of berberine on diabetes induced by alloxan and a high-fat/high-cholesterol diet in rats. , 2006, Journal of ethnopharmacology.

[8]  Ji-sheng Ma,et al.  [Qualitative and quantitative determination of the main components of huanglianjiedu decoction by HPLC-UV/MS]. , 2006, Yao xue xue bao = Acta pharmaceutica Sinica.

[9]  Y. Kadono,et al.  Osteoimmunology: interplay between the immune system and bone metabolism. , 2006, Annual review of immunology.

[10]  Ting Han,et al.  Simultaneous determination of four active alkaloids from a traditional Chinese medicine Corydalis saxicola Bunting. (Yanhuanglian) in plasma and urine samples by LC-MS-MS. , 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[11]  E. Cho,et al.  Protective role of Coptidis Rhizoma alkaloids against peroxynitrite‐induced damage to renal tubular epithelial cells , 2005, The Journal of pharmacy and pharmacology.

[12]  F. Saltel,et al.  Apatite-mediated actin dynamics in resorbing osteoclasts. , 2004, Molecular biology of the cell.

[13]  S. Teitelbaum.  RANKing c-Jun in osteoclast development. , 2004, The Journal of clinical investigation.

[14]  David L. Lacey,et al.  Osteoclast differentiation and activation , 2003, Nature.

[15]  F. Saltel,et al.  Podosomes display actin turnover and dynamic self-organization in osteoclasts expressing actin-green fluorescent protein. , 2003, Molecular biology of the cell.

[16]  T. Martin,et al.  Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function. , 2000, Endocrinology.

[17]  H. Väänänen,et al.  The cell biology of osteoclast function. , 2000, Journal of cell science.

[18]  Sundeep Khosla,et al.  The Roles of Osteoprotegerin and Osteoprotegerin Ligand in the Paracrine Regulation of Bone Resorption , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[19]  T. Miyata,et al.  Commitment and Differentiation of Osteoclast Precursor Cells by the Sequential Expression of C-Fms and Receptor Activator of Nuclear Factor κb (Rank) Receptors , 1999, The Journal of experimental medicine.

[20]  T. Martin,et al.  Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. , 1999, Endocrine reviews.

[21]  N. Nemoto,et al.  The effect of Kampo formulae on bone resorption in vitro and in vivo. I. Active constituents of Tsu-kan-gan. , 1998, Biological & pharmaceutical bulletin.

[22]  Ulrich Siebenlist,et al.  Requirement for NF-κB in osteoclast and B-cell development , 1997 .

[23]  N. Takahashi,et al.  Calcitonin-induced changes in the cytoskeleton are mediated by a signal pathway associated with protein kinase A in osteoclasts. , 1996, Endocrinology.

[24]  Sakae Tanaka,et al.  Wortmannin, a specific inhibitor of phosphatidylinositol‐3 kinase, blocks osteoclastic bone resorption , 1995, FEBS letters.

[25]  Paivi,et al.  Calcitonin, prostaglandin E2, and dibutyryl cyclic adenosine 3',5'-monophosphate disperse the specific microfilament structure in resorbing osteoclasts. , 1990, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[26]  J. Phillipson,et al.  Ethnopharmacology and Western medicine. , 1989, Journal of ethnopharmacology.

[27]  T. Chambers,et al.  Calcitonin alters behaviour of isolated osteoclasts , 1982, The Journal of pathology.

[28]  N. Udagawa,et al.  Generation of osteoclasts in vitro, and assay of osteoclast activity. , 2007, Methods in molecular medicine.

[29]  C. Chi,et al.  The anti-inflammatory potential of berberine in vitro and in vivo. , 2004, Cancer letters.

[30]  J. Caamaño,et al.  Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2. , 1997, Nature medicine.